Science & Innovation
We leverage our knowledge of pathophysiological processes and disease characteristics to pioneer new potential treatments. There’s more to come as we continue to chase the possibilities and strive to make a difference for people with neurological conditions everywhere.
Biogen R&D is driven by the potential to transform the lives of people. We work in disease areas with some of the greatest unmet need. We work fearlessly, knowing that bold new possibilities await discovery. As a leading global biotechnology company, we work toward those once-in-a-lifetime moments that could become a historic point in our pursuit of innovative treatments.
Biogen is committed to investing in clinical trials to advance our knowledge and expertise as a pioneer in neuroscience. Currently, we have over 1,200 active study sites across 47 countries, with approximately 30,000 people enrolled in these programs.
We are humbled by the opportunity to collaborate with the community to bring forward information in the hope of uncovering important and breakthrough medicines.
We also recognise the importance of clinical research and its broader contribution to the development of new medical interventions and are determined to help improve health equity for people living with neurological conditions.
In doing so, we promote inclusivity in our clinical trials by simplifying pathways and limiting delays for people to access potential new treatments as early as possible.
We will continue to advocate for the community and remain committed to enabling broader contributions to the development of medical therapies.